Jean F. Holloway Esq.
Net Worth

Last updated:

What is Jean F. Holloway Esq. net worth?

The estimated net worth of Ms. Jean F. Holloway Esq. is at least $6,334,209 as of 31 Aug 2021. She owns shares worth $1,547,818 as insider, has earned $500,051 from insider trading and has received compensation worth at least $4,286,340 in Artivion, Inc..

What is the salary of Jean F. Holloway Esq.?

Ms. Jean F. Holloway Esq. salary is $476,260 per year as Senior Vice President, Gen. Counsel, Chief Compliance Officer & Corporation Sec. in Artivion, Inc..

How old is Jean F. Holloway Esq.?

Ms. Jean F. Holloway Esq. is 68 years old, born in 1957.

What stocks does Jean F. Holloway Esq. currently own?

As insider, Ms. Jean F. Holloway Esq. owns shares in one company:

Company Title Shares Price per share Total value
Artivion, Inc. (CRY) Senior Vice President, Gen. Counsel, Chief Compliance Officer & Corporation Sec. 86,567 $17.88 $1,547,818

What does Artivion, Inc. do?

Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. It offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; On-X prosthetic aortic and mitral heart valve, and On-X ascending aortic prosthesis; cardiac preservation services; PhotoFix, a bovine pericardial patch; and E-vita OPEN PLUS and E-vita OPEN NEO, a hybrid stent graft system. The company also provides E-xtra DESIGN ENGINEERING products for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-nya, a thoracic stent graft system for the minimally invasive repair of lesions of the descending aorta; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, an abdominal aortic aneurysms stent graft system. In addition, it offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; and cardiac laser therapy products, such as SolarGen 2100s Console and SoloGrip III disposable handpieces. Further, the company sells CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as offers pyrolytic carbon coating services to other medical device manufacturers. The company serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion Inc. in January 2022. Artivion Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.

Jean F. Holloway Esq. insider trading

Artivion, Inc.

Ms. Jean F. Holloway Esq. has made 12 insider trades between 2016-2021, according to the Form 4 filled with the SEC. Most recently she sold 663 units of CRY stock worth $17,566 on 31 Aug 2021.

The largest trade she's ever made was exercising 13,236 units of CRY stock on 5 May 2021. As of 31 Aug 2021 she still owns at least 86,567 units of CRY stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 663 $26.5 $17,566
Sale
Common Stock 6,618 N/A N/A
Option
Common Stock 13,236 N/A N/A
Option
Common Stock 13,236 $10.24 $135,537
Option
Common Stock 6,618 N/A N/A
Option
Common Stock 13,236 $10.24 $135,537
Sale
Common Stock 6,618 $10.24 $67,768
Sale
Common Stock 1,693 $25.28 $42,797
Option
ESPP 189 $16.18 $3,057
Option
Common Stock 189 $16.18 $3,057
Option
ESPP 790 $16.3 $12,873
Option
Stock Options(Right to buy) 8,458 $9.64 $81,535
Option
COMMON STOCK 8,458 $9.64 $81,535
Sale
COMMON STOCK 8,458 $9.64 $81,535
Sale
Common Stock 195 $9.64 $1,880
Option
Common Stock 195 $9.64 $1,880
Option
Stock Options (Right to buy) 195 $9.64 $1,880
Option
Common Stock 790 $16.3 $12,873
Option
ESPP 356 $23.03 $8,198
Option
Stock Options(Right to buy) 3,000 $10.24 $30,720
Option
Common Stock 3,000 $10.24 $30,720
Sale
Common Stock 3,000 $10.24 $30,720
Option
Common Stock 356 $23.03 $8,198
Option
ESPP 498 $24.12 $12,013
Option
Common Stock 8,654 $9.64 $83,425
Option
Stock Options (Right to Buy) 8,654 $9.64 $83,425
Sale
Common Stock 8,654 $9.64 $83,425
Option
Common Stock 10,000 $10.24 $102,400
Sale
Common Stock 10,000 $10.24 $102,400
Option
Stock Options (Right to buy) 10,000 $10.24 $102,400
Option
Common Stock 498 $24.12 $12,013
Option
Common Stock 307 $23.67 $7,268
Option
Stock Option(Right to Buy) 307 $23.67 $7,268
Sale
Common Stock 1,500 $10.28 $15,420
Option
Stock Option (Right to Buy) 1,500 $10.28 $15,420
Option
Common Stock 1,500 $10.28 $15,420
Option
Stock Option (Right to Buy) 4,000 $10.28 $41,120
Option
Common Stock 4,000 $10.28 $41,120
Sale
Common Stock 4,000 $10.28 $41,120
Sale
Common Stock 1,500 $10.28 $15,420
Option
Common Stock 1,500 $10.28 $15,420
Option
Stock Option (Right to Buy) 1,500 $10.28 $15,420
Option
ESPP 861 $16.24 $13,978
Option
Common Stock 861 $16.24 $13,978
Option
Stock Option (Right to Buy) 567 $16.28 $9,230
Option
Common Stock 567 $16.28 $9,230
Option
Stock Option (Right to Buy) 714 $16.28 $11,622
Option
Common Stock 714 $16.28 $11,622
Option
Common Stock 1,000 $10.2 $10,200
Option
Common Stock 3,000 $9.64 $28,920
Option
Stock Option 3,000 $9.64 $28,920
Option
Common Stock 1,205 $9.16 $11,041

Artivion key executives

Artivion, Inc. executives and other stock owners filed with the SEC:

  • Mr. David Ashley Lee CPA, CPA (60) Executive Vice President, Chief Operating Officer & Chief Financial Officer
  • Mr. James Patrick Mackin (58) Chairman, Pres & Chief Executive Officer
  • Mr. John E. Davis (60) Senior Vice President of Global Sales & Marketing
  • Ms. Jean F. Holloway Esq. (68) Senior Vice President, Gen. Counsel, Chief Compliance Officer & Corporation Sec.